We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amarin Takes Next Step for Hypertriglyceridemia Drug
Amarin Takes Next Step for Hypertriglyceridemia Drug
July 25, 2008
Amarin has the FDA’s approval to begin a Phase III study of its experimental compound AMR101 to treat hypertriglyceridemia, according to the company.